Hoge Stephen's Form 4 filing
Moderna, Inc. (MRNA) · filed Feb 25, 2022
- Accession no.
- 0001127602-22-006809
- Filed
- Feb 25, 2022
- Trade date
- Feb 23-24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.80M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoge StephenCIK 0001760669 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $10.90 | +$54,500 | 1,615,791 | Direct | |
| Feb 23, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $0.99 | +$9,900 | 1,625,791 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −1,802 | $135.69F2 | −$244,513.38 | 1,623,989 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −3,698 | $136.80F3 | −$505,886.4 | 1,620,291 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −2,300 | $137.83F4 | −$317,009 | 1,617,991 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −800 | $138.98F5 | −$111,184 | 1,617,191 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −100 | $139.67 | −$13,967 | 1,617,091 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −200 | $141.19F6 | −$28,238 | 1,616,891 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −800 | $142.32F7 | −$113,856 | 1,616,091 | Direct | |
| Feb 23, 2022 | Common Stock | SSaleDisposed | −5,300 | $144.60F8 | −$766,380 | 1,610,791 | Direct | |
| Feb 24, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $10.90 | +$54,500 | 1,615,791 | Direct | |
| Feb 24, 2022 | Common Stock | SSaleDisposed | −5,000 | $139.80 | −$699,000 | 1,610,791 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 131,972 | Direct | |
| Feb 23, 2022 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 117,431 | Direct | |
| Feb 24, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 126,972 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.28 to $136.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.32 to $137.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.53 to $138.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.65 to $139.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.70 to $141.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.90 to $142.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.34 to $145.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.